Bellevue Group AG - HARMONY BIOSCIENCES HLDGS IN ownership

HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 213 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.7%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of HARMONY BIOSCIENCES HLDGS IN
ValueSharesWeighting
Q1 2023$19,526,202
-40.6%
598,046
+0.3%
0.28%
-35.1%
Q4 2022$32,850,179
+12.9%
596,192
-9.3%
0.44%
+4.3%
Q3 2022$29,107,000
-15.0%
657,188
-6.4%
0.42%
-13.6%
Q2 2022$34,240,000
+463.3%
702,068
+461.8%
0.48%
+581.7%
Q1 2022$6,079,000
+17.7%
124,961
+3.1%
0.07%
+34.0%
Q4 2021$5,166,000
+4.2%
121,161
-6.3%
0.05%
+6.0%
Q3 2021$4,956,000129,2890.05%
Other shareholders
HARMONY BIOSCIENCES HLDGS IN shareholders Q1 2023
NameSharesValueWeighting ↓
Valor Management LLC 11,218,033$618,113,61997.50%
venBio Partners LLC 1,035,396$57,050,32017.69%
Vivo Capital, LLC 2,606,247$143,60416.53%
Nan Fung Group Holdings Ltd 368,665$20,313,44214.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 264,500$14,560,7254.50%
NEUMEIER POMA INVESTMENT COUNSEL LLC 685,340$37,762,2343.51%
ASHFORD CAPITAL MANAGEMENT INC 356,638$19,650,7543.05%
TANG CAPITAL MANAGEMENT LLC 281,200$15,494,1202.25%
MPM BioImpact LLC 139,377$7,679,6731.99%
O'Neil Global Advisors, Inc. 7,335$4041.86%
View complete list of HARMONY BIOSCIENCES HLDGS IN shareholders